These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 20936927)

  • 21. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
    J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation.
    Sinnaeve PR; Brueckmann M; Clemens A; Oldgren J; Eikelboom J; Healey JS
    J Intern Med; 2012 Jan; 271(1):15-24. PubMed ID: 21995885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 24. Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment.
    Eikelboom JW; O'Donnell M; Yusuf S; Diaz R; Flaker G; Hart R; Hohnloser S; Joyner C; Lawrence J; Pais P; Pogue J; Synhorst D; Connolly SJ
    Am Heart J; 2010 Mar; 159(3):348-353.e1. PubMed ID: 20211294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.
    Roskell NS; Lip GY; Noack H; Clemens A; Plumb JM
    Thromb Haemost; 2010 Dec; 104(6):1106-15. PubMed ID: 20967400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stroke prevention in atrial fibrillation.
    Verheugt FW
    Neth J Med; 2006 Feb; 64(2):31-3. PubMed ID: 16517985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacoeconomics of atrial fibrillation and stroke prevention.
    Bushnell CD; Matchar DB
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S66-71. PubMed ID: 15152748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clopidogrel hydrogen sulphate for atrial fibrillation.
    Garg N; Rajpurohit N; Flaker G
    Expert Opin Pharmacother; 2011 Aug; 12(11):1781-7. PubMed ID: 21663525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?].
    Calvo Romero JM
    Rev Clin Esp; 2011 Mar; 211(3):142-6. PubMed ID: 21371701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New frontiers for stroke prevention in atrial fibrillation.
    Prasad V; Kaplan RM; Passman RS
    Cerebrovasc Dis; 2012; 33(3):199-208. PubMed ID: 22261539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual antiplatelet therapy is not optimal for stroke prevention in patients with atrial fibrillation.
    Chamorro A
    Int J Stroke; 2010 Feb; 5(1):28-9. PubMed ID: 20088990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.
    Schirmer SH; Baumhäkel M; Neuberger HR; Hohnloser SH; van Gelder IC; Lip GY; Böhm M
    J Am Coll Cardiol; 2010 Dec; 56(25):2067-76. PubMed ID: 21144965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice.
    Go AS
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S58-65. PubMed ID: 15152747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet agents in stroke prevention: acute and long-term treatment strategies.
    Weber R; Weimar C; Diener HC
    Hamostaseologie; 2009 Nov; 29(4):326-33. PubMed ID: 19882077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic prophylaxis in elderly patients with atrial fibrillation.
    Hylek EM
    Semin Thromb Hemost; 2009 Sep; 35(6):548-53. PubMed ID: 19787558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic management of atrial fibrillation for stroke prevention in older people.
    Tong DC; Albers GW
    Clin Geriatr Med; 1999 Nov; 15(4):645-62. PubMed ID: 10499928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C; Singh BN
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
    Syed TM; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry).
    Kowey PR; Reiffel JA; Myerburg R; Naccarelli GV; Packer DL; Pratt CM; Reiter MJ; Waldo AL;
    Am J Cardiol; 2010 Apr; 105(8):1130-4. PubMed ID: 20381665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.